CoreCap Advisors’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Sell |
2,859
-1,825
| -39% | -$11.6K | ﹤0.01% | 1645 |
|
|
2025
Q1 | $22.8K | Sell |
4,684
-3,550
| -43% | -$17.3K | ﹤0.01% | 1477 |
|
|
2024
Q4 | $78.7K | Sell |
8,234
-2,500
| -23% | -$23.9K | ﹤0.01% | 1013 |
|
|
2024
Q3 | $89.6K | Sell |
10,734
-13,750
| -56% | -$115K | ﹤0.01% | 962 |
|
|
2024
Q2 | $167K | Sell |
24,484
-6,700
| -21% | -$45.7K | 0.02% | 395 |
|
|
2024
Q1 | $78.9K | Buy |
31,184
+17,450
| +127% | +$44.1K | ﹤0.01% | 937 |
|
|
2023
Q4 | $33K | Buy |
+13,734
| New | +$33K | ﹤0.01% | 596 |
|
|
2022
Q4 | $106 | Buy |
+9
| New | +$106 | ﹤0.01% | 2308 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | – | – | 944 |
|
|
2022
Q2 | $0 | Buy |
+9
| New | – | ﹤0.01% | 2165 |
|
|
2022
Q1 | – | Sell |
-9
| Closed | -$1K | – | 952 |
|
|
2021
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 2103 |
|